Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gideon Gross

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Annual Review of Pharmacology and Toxicology|January 8, 2016
Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell TherapyGideon Gross, Zelig Eshhar
Transplant Immunology|March 25, 2019
Endowing human CD8 T cells with a veto-like recognition capacity via the electroporation of MHC-I/CD3ζ mRNAOrly Weissberg, Gideon Gross
Frontiers in Immunology|May 16, 2022
Editorial: Implementing Logic Gates in Adoptive Cell TherapyGideon Gross, Yaron Carmi, Hinrich Abken
Cancer Journal (Sudbury, Mass.)|March 27, 2014
The emergence of T-bodies/CAR T cellsZelig Eshhar, Tova Waks, Gideon Gross
Frontiers in Immunology|November 22, 2021
Implementing Logic Gates for Safer Immunotherapy of CancerMohammed Azharuddin Savanur, Hadas Weinstein-Marom, Gideon Gross
Annals of the New York Academy of Sciences|February 8, 2013
Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulinGal Cafri, Alon Margalit, Esther Tzehoval, et al.
International Immunology|October 21, 2003
Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cellsAlon Margalit, Sigal Fishman, Dikla Berko, et al.
Journal of Immunological Methods|November 8, 2003
In-cell generation of antibody single-chain Fv transcripts by targeted RNA trans-splicingJacob Schlesinger, Dina Arama, Hava Noy, et al.
Biochemical and Biophysical Research Communications|June 23, 2009
Enhanced HIV-1 neutralization by a CD4-VH3-IgG1 fusion proteinRonit Meyuhas, Hava Noy, Sigal Fishman, et al.
Immunology|June 20, 2014
Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cellsShira Perez, Sigal Fishman, Amos Bordowitz, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Annual Review of Pharmacology and Toxicology|January 8, 2016
Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell TherapyGideon Gross, Zelig Eshhar
Transplant Immunology|March 25, 2019
Endowing human CD8 T cells with a veto-like recognition capacity via the electroporation of MHC-I/CD3ζ mRNAOrly Weissberg, Gideon Gross
Frontiers in Immunology|May 16, 2022
Editorial: Implementing Logic Gates in Adoptive Cell TherapyGideon Gross, Yaron Carmi, Hinrich Abken
Cancer Journal (Sudbury, Mass.)|March 27, 2014
The emergence of T-bodies/CAR T cellsZelig Eshhar, Tova Waks, Gideon Gross
Frontiers in Immunology|November 22, 2021
Implementing Logic Gates for Safer Immunotherapy of CancerMohammed Azharuddin Savanur, Hadas Weinstein-Marom, Gideon Gross
Annals of the New York Academy of Sciences|February 8, 2013
Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulinGal Cafri, Alon Margalit, Esther Tzehoval, et al.
International Immunology|October 21, 2003
Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cellsAlon Margalit, Sigal Fishman, Dikla Berko, et al.
Journal of Immunological Methods|November 8, 2003
In-cell generation of antibody single-chain Fv transcripts by targeted RNA trans-splicingJacob Schlesinger, Dina Arama, Hava Noy, et al.
Biochemical and Biophysical Research Communications|June 23, 2009
Enhanced HIV-1 neutralization by a CD4-VH3-IgG1 fusion proteinRonit Meyuhas, Hava Noy, Sigal Fishman, et al.
Immunology|June 20, 2014
Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cellsShira Perez, Sigal Fishman, Amos Bordowitz, et al.
Pageof 4